Skip to main content

Table 1 Demographics data of patients

From: Efficacy of adipose stromal cells-enriched high-density fat graft combined with BTX-A for Raynaud’s phenomenon: a prospective cohort study

Patient

Gender

Age (years)

Diagnosis

Ulcers (pre-operation)

Duration of Ulcers (week)

Prior Intervention

1

M

61

SRP

None

None

None

2

F

43

Scleroderma

R

52

Botox, sympathectomy

3

M

54

SRP

BH

9

calcium channel inhibitors

4

M

63

Scleroderma

BH

56

Botox, sympathectomy

5

F

46

MCTD

R

13

calcium channel inhibitors

6

F

54

Scleroderma

R

1

None

7

F

48

Scleroderma

R

8

Botox

8

F

78

SRP

BH

1

None

9

M

50

PRP

BH

4

None

10

M

72

SRP

BH

12

calcium channel inhibitors

11

F

67

SRP

None

None

None

  1. Note: PRP, primary Raynaud’s Phenomenon; SRP, secondary Raynaud’s Phenomenon; MCTD, mixed connective tissue disorder; R, right hand; BH, both hands. None indicates that the patient did not receive the specific treatment listed, but it does not imply that the patient was treatment-naive. All patients had previously received standard treatments but did not achieve satisfactory results before being considered for the experimental procedure